
@askrenal
@askrenal
Crowdsourcing answers to Nephrology questions!
A @nephjc initiative, based @UAlberta #Academic a/c.
Bot Questions? DM - @dr_nikhilshah
ID: 807056923103109120
http://nephjc.com 09-12-2016 02:58:59
8,8K Tweet
9,9K Followers
112 Following

An Ask Renal question for the #NephTwitter #NephX by - Renal Path Labs 👇 x.com/RenalPathLabs/…




Question for #NephX #NephTwitter - diplomaticdoc: Pallavi Prasad MD DNB @askrenal But yes, mam. I guess AAV or LN in remission could still progress to CKD. Apparently, even Bartter’s syndrome has a risk of progression to ckd. pmc.ncbi.nlm.nih.gov/articles/PMC10… Even … x.com/diplomaticdoc/…


An Ask Renal question for the #NephTwitter #NephX by - soda_troubles,https://med-mastodon.com/@haysam 👇 x.com/set_fortess/st…

An Ask Renal question for the #NephTwitter #NephX by - Kenar Jhaveri 👇 x.com/kdjhaveri/stat…



An Ask Renal question for the #NephTwitter #NephX by - NephroNerd 👇 x.com/DrNephroNerd/s…


An Ask Renal question for the #NephTwitter #NephX by - Carmen Cajina 🇳🇮 👇 x.com/CajinaCarmen/s…


Question for #NephX #NephTwitter - GlassockJ: Kenar Jhaveri Sayna Norouzi, MD, FASN @askrenal Deepa Malieckal MD No, never. Not tested. x.com/GlassockJ/stat…

Question for #NephX #NephTwitter - GlassockJ: Kenar Jhaveri Sayna Norouzi, MD, FASN @askrenal Deepa Malieckal MD Eculuzumab but not avacopan has been used with uncertain benefits added to SOC. Complenent activation and MAC fornafion are involved in glomerular injury. x.com/GlassockJ/stat…

An Ask Renal question for the #NephTwitter #NephX by - Renal Path Labs 👇 x.com/RenalPathLabs/…

An Ask Renal question for the #NephTwitter #NephX by - Alicja Rosołowska 👇 x.com/alunieczka/sta…

Question for #NephX #NephTwitter - BajinderR: Alicja Rosołowska @askrenal Brad H Rovin Prof Liz B 🇬🇧🇮🇱🇺🇦🇵🇸 Aniftolimab x.com/BajinderR/stat…

Question for #NephX #NephTwitter - DrNephronMrMike: Alicja Rosołowska @askrenal Brad H Rovin Prof Liz B 🇬🇧🇮🇱🇺🇦🇵🇸 I would go with rituximab x.com/DrNephronMrMik…